1. Liu, Tiezhu, Li, Jiajia, Wang, Xueqi, Wang, Shiwen, Liang, Mifang. 2023. Knockout of CLTC gene reduces but not completely block SFTSV infection. In PloS one, 18, e0285673. doi:10.1371/journal.pone.0285673. https://pubmed.ncbi.nlm.nih.gov/37624798/
2. Bridge, Julia A, Sumegi, Janos, Royce, Thomas, Baker, Michael, Linos, Konstantinos. 2020. A novel CLTC-FOSB gene fusion in pseudomyogenic hemangioendothelioma of bone. In Genes, chromosomes & cancer, 60, 38-42. doi:10.1002/gcc.22891. https://pubmed.ncbi.nlm.nih.gov/32749039/
3. Hamdan, Fadi F, Myers, Candace T, Cossette, Patrick, Minassian, Berge A, Michaud, Jacques L. . High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies. In American journal of human genetics, 101, 664-685. doi:10.1016/j.ajhg.2017.09.008. https://pubmed.ncbi.nlm.nih.gov/29100083/
4. Nabais Sá, Maria J, Venselaar, Hanka, Wiel, Laurens, de Brouwer, Arjan P M, Koolen, David A. 2019. De novo CLTC variants are associated with a variable phenotype from mild to severe intellectual disability, microcephaly, hypoplasia of the corpus callosum, and epilepsy. In Genetics in medicine : official journal of the American College of Medical Genetics, 22, 797-802. doi:10.1038/s41436-019-0703-y. https://pubmed.ncbi.nlm.nih.gov/31776469/